Assembly Biosciences, Inc. (ASMB) Operating margin 2017–2025
Assembly Biosciences, Inc. (ASMB) operating margin by fiscal year — reported operating income divided by reported revenue.
-16.8%FY2025 · since FY2017: -579.1% → -16.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -16.8% | +142.5 pp |
| FY2024 | -159.3% | +743.2 pp |
| FY2023 | -902.5% | — |
| FY2021 | -2121.7% | -2039.8 pp |
| FY2020 | -81.9% | +561.6 pp |
| FY2019 | -643.4% | -17.0 pp |
| FY2018 | -626.4% | -47.3 pp |
| FY2017 | -579.1% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More ASMB financial trends
ASMB RevenueASMB Net incomeASMB Net marginASMB Gross profitASMB Gross marginASMB Operating incomeASMB Operating cash flowASMB Free cash flowASMB Capital expendituresASMB Return on equityASMB Stock buybacksASMB Dividends paidASMB Total assetsASMB Total liabilitiesASMB Shareholders’ equityASMB overview →